Cart
sales@molnova.com
hGPR91 antagonist 3
CAS No. 1314796-31-0
hGPR91 antagonist 3( —— )
Catalog No. M35675 CAS No. 1314796-31-0
hGPR91 antagonist 3 is an orally active, potent, and selective hGPR91 antagonist. hGPR91 antagonist 3 is used to study hypertension, autoimmune diseases, and retinal angiogenesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 315 | In Stock |
|
| 5MG | 312 | In Stock |
|
| 10MG | 518 | In Stock |
|
| 25MG | 835 | In Stock |
|
| 50MG | 1107 | In Stock |
|
| 100MG | 1516 | In Stock |
|
| 200MG | 2037 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamehGPR91 antagonist 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionhGPR91 antagonist 3 is an orally active, potent, and selective hGPR91 antagonist. hGPR91 antagonist 3 is used to study hypertension, autoimmune diseases, and retinal angiogenesis.
-
DescriptionhGPR91 antagonist 3 (Compound 5g) is a potent and orally active GPR91 antagonist with IC50 of 35 nM and 135 nM, for human GPR91 and rat GPR91, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1314796-31-0
-
Formula Weight458.41
-
Molecular FormulaC23H18F4N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (218.15 mM; Ultrasonic (<80°C)
-
SMILESO=C(NCC=1ON=C(C1)C=2C=CC(F)=C(C2)C(F)(F)F)CCCC=3N=C4N=CC=CC4=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bhuniya D, et al. Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg Med Chem Lett. 2011;21(12):3596-3602. ?
molnova catalog
related products
-
3-chloro-5-hydroxybe...
3-chloro-5-hydroxy Benzoic Acid (3-chloro-5-hydroxy BA) is an agonist of GPR81 (EC50 : 16 μM).
-
FL104
FL104 is a potent agonist of small-molecule urotensin II receptor, pEC50= 7.11.
-
MBX2982
MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.
